Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-06 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-03-26 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
MNPR | Monopar Therapeutics | 7.39 | -0.35 | -4.52% | 84.6M |
You can purchase shares of Monopar Therapeutics (NASDAQ: MNPR) through any online brokerage.
Other companies in Monopar Therapeutics’s space includes: PolarityTE (NASDAQ:PTE), Cleveland BioLabs (NASDAQ:CBLI) and Biocept (NASDAQ:BIOC).
The latest price target for Monopar Therapeutics (NASDAQ: MNPR) was reported by Roth Capital on 2021-01-28. The analyst firm set a price target for 49.00 expecting MNPR to rise to within 12 months (a possible 563.06% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Monopar Therapeutics (NASDAQ: MNPR) is $7.39 last updated Thu Feb 25 2021 21:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Monopar Therapeutics.
There is no upcoming split for Monopar Therapeutics.